PepGen PEPG
NASDAQ PEPG
$5.26 +0.65 (+14.10%)
At close: Nov 11, 2026 · 4:00 PM EST

PepGen (PEPG) Cash from Restructuring (2022 - 2025)

Updated

PepGen's Cash from Restructuring came in at -$11,000 for Q2 2025.

Analysis

PepGen (PEPG) Cash from Restructuring (2022 - 2025) Analysis & Trends

For FY2024, PepGen's Cash from Restructuring was $70,000.

  • Going back by year, Cash from Restructuring was $134,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 PepGen 319.29 Mn -183.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -11,000.00
Mar 31, 2025 11,000.00
Dec 31, 2024 50,000.00
Mar 31, 2024 20,000.00
Dec 31, 2022 -2,000.00
API Access

PepGen Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=PEPG&period=max&api_key=YOUR_API_KEY